Acute self-limiting and chronic liver injury are both associated with activ
ation and proliferation of hepatic stellate cells (HSCs). In chronic injury
, activated stellate cells are the major source of the collagens that compr
ise fibrosis and cirrhosis, as well as of the tissue inhibitors of metallop
roteinases (TIMPs) which inhibit collagen degradation. Recovery from acute
and chronic injury is characterized by apoptosis of activated-HSCs, which r
emoves extracellular matrix-producing cells that are also expressing TIMPs,
thereby relieving the inhibition of matrix degradation. HSC apoptosis is r
egulated in progressive injury and counterbalances cell proliferation. Apop
tosis probably also represents a default pathway for the HSCs. The survival
of activated HSCs in liver injury is dependent on soluble growth factors a
nd cytokines, and on components of the fibrotic matrix. Additionally, stimu
lation of death receptors expressed on HSCs can precipitate their apoptosis
. Our increasing understanding of the process of stellate cell behavior in
recovery from injury is likely to be important to the design of antifibroti
c therapies.